← RHYTHM PHARMACEUTICALS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $6.5m | $34.2m | $49.5m | $62.3m | $100.9m | $59.2m | $127.7m | $60.1m | $89.1m | $54.3m | |
| Prepaid Expense and Other Assets, Current | $638k | $2.6m | $6.6m | $9.9m | $8.9m | $12.5m | $11.8m | $8.9m | $16.4m | $26.1m | |
| Cash, Cash Equivalents, and Short-term Investments | $10.5m | $148.1m | $252.1m | $292.5m | $172.8m | $294.9m | $333.3m | $275.8m | $320.6m | $388.9m | |
| Short-term Investments | $4.0m | $113.8m | $202.5m | $230.2m | $71.9m | $235.6m | $205.6m | $215.8m | $231.4m | $334.6m | |
| Inventory, Net | — | — | — | — | — | $111k | $2.9m | $8.6m | $18.7m | $25.8m | |
| Assets, Current | $11.2m | $150.7m | $258.7m | $302.4m | $181.7m | $308.4m | $354.2m | $308.3m | $374.2m | $466.9m | |
| Property, Plant and Equipment, Net | $930k | $840k | $1.1m | $3.7m | $3.2m | $2.8m | $2.2m | $1.3m | $632k | $1.1m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $2.0m | $1.8m | $1.5m | $1.2m | $781k | $3.5m | $3.0m | |
| Other Assets, Noncurrent | — | — | — | — | — | — | — | $15.0m | $7.3m | $3.3m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | $1.0m | $6.2m | $14.9m | $18.5m | $26.1m | |
| Accrued Liabilities, Current | $2.7m | $4.2m | $5.9m | $13.5m | $12.6m | $30.1m | $32.9m | $48.3m | $62.7m | $83.9m | |
| Assets | $12.3m | $151.7m | $260.2m | $308.5m | $187.1m | $329.5m | $382.5m | $332.7m | $392.3m | $480.2m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $472k | $535k | $606k | $684k | $770k | — | $650k | |
| Accounts Payable, Current | $1.9m | $2.4m | $7.6m | $10.4m | $4.9m | $5.7m | $4.8m | $4.9m | $12.3m | $13.9m | |
| Operating Lease, Liability, Noncurrent | — | — | — | — | — | $1.9m | $1.3m | $490k | $3.9m | $3.3m | |
| Deferred Revenue, Current | — | — | — | — | — | $7.0m | $1.4m | $1.3m | $1.3m | $194k | |
| Deferred Revenue, Noncurrent | — | — | — | — | — | — | $75.8m | $106.1m | — | — | |
| Long-term Debt, Current Maturities | — | — | — | — | — | — | — | — | $1.5m | $7.3m | |
| Long-term Debt, Excluding Current Maturities | — | — | — | — | — | — | — | — | $108.3m | $100.9m | |
| Liabilities, Current | $4.7m | $6.7m | $13.6m | $24.4m | $18.0m | $43.4m | $39.8m | $55.2m | $115.5m | $105.9m | |
| Liabilities | $5.0m | $6.9m | $14.0m | $27.5m | $20.5m | $45.4m | $118.2m | $163.0m | $227.7m | $210.2m | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $10k | $27k | $34k | $44k | $44k | $50k | $56k | $59k | $61k | $67k | |
| Additional Paid in Capital | $43.8m | $255.0m | $430.8m | $606.3m | $625.8m | $813.0m | $974.4m | $1.1b | $1.2b | $1.5b | |
| Retained Earnings (Accumulated Deficit) | ($76.5m) | ($110.3m) | ($184.6m) | ($325.3m) | ($459.3m) | ($528.9m) | ($710.1m) | ($894.7m) | ($1.2b) | ($1.4b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | — | — | — | $49k | ($1k) | ($92k) | $134k | ($39k) | ($796k) | |
| Stockholders' Equity Attributable to Parent | ($32.7m) | $144.8m | $246.3m | $281.0m | $166.5m | $284.2m | $264.3m | $169.8m | $21.7m | $139.1m | |
| Liabilities and Equity | $12.3m | $151.7m | $260.2m | $308.5m | $187.1m | $329.5m | $382.5m | $332.7m | $392.3m | $480.2m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.